Will COVID-19 Be the Tipping Point for Primary HPV Self-sampling?

Area of Science:

• Gynecology
• Public Health
• Epidemiology

Background:

• Cervical cancer screening programs have been impacted by COVID-19.
• Self-sampling offers a socially distanced alternative for cervical screening.
• This method has the potential to reach underserved populations.

Purpose of the Study:

• To evaluate the effectiveness of self-sampling as a primary cervical screening option.
• To assess the impact of self-sampling on program outcomes using a modeling study.
• To identify challenges and opportunities for implementing self-sampling.

Main Methods:

• A modeling study was conducted, using Australia as an example.
• The study compared the effectiveness of primary self-sampling with current screening programs.
• Sensitivity of self-sampling was considered in the modeling.

Main Results:

• Primary self-sampling is projected to be more effective than the current screening program.
• The study suggests improved program effectiveness even with potentially lower sensitivity of self-sampling.
• Evidence indicates self-sampling is non-inferior to clinician-taken samples.

Conclusions:

• Self-sampling is a disruptive technology for cervical screening.
• COVID-19 may accelerate the adoption of self-sampling for cervical cancer screening.
• Overcoming regulatory hurdles and ensuring clear communication are crucial for wider introduction.